|
|
|
|
|
|
Renoprotective efficacy of different doses of statins in experimental acute renal failure
Zeleniuk VH, Zamors'kyĭ II, Horoshko OM.
Bukovinsky Medical University, Ministry of Public Health, Ukraine
DOI: https://doi.org/10.15407/fz60.02.075
Abstract
The effect of three statins (atorvastatin, lovastatin, simvastatin)
on the renal function under conditions of experimental
acute renal failure in rats was studied. The relatively
effective doses were found to possess the most considerable
renoprotective properties. All the statins were established to
cause the restoration of functional activity of the kidneys under
conditions of experimental rhabdomyolytic acute renal failure
at various doses, but with the dose of 20 mg/kg they showed
the most significant improvement in key indices of kidney
function: an increase in diuresis by an average of 32% and
glomerular filtration rate by an average of 90%, reduction of
proteinuria in more than twice. At the same time, in the animals
with acute renal failure the level of creatine phosphokinase was
increased by 141%. However, the activity of blood plasma
creatine phosphokinase of all animals treated with statins was
14% higher than in the intact control, indicating the minor
myotrphic activity of statins in selected mode of administration.
Thus, the use of 20 mg/kg dose is the most reasonable from the
standpoint of renoprotective efficacy and safety
Keywords:
acute renal failure, statins, renoprotection, creatinephosphokinase.
References
- D'Amico G. Statins and renal diseases: from primary prevention to renal replacement therapy. J. Am. Soc. Nephrol. 2006; 17: S148-S152.
CrossRef
PubMed
- Epstein M., Campese V.M. Pleiotropic effects of 3-hydroxy- 3-methylglutaryl coenzyme A reductase inhibitors on renal function. Am. J. Kidney Dis. 2005; 45: 2-14.
CrossRef
- Tonelli M. Do statins protect the kidney as well as the heart? Cardiology rounds. 2006; Vol. 10, Iss. 6: 171-173.
- Navaneethan S.D., Pansini F., Perkovic V. et al. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis (Review). The Cochrane Library. 2009; Iss. 3.
- Atroshchenko E.S. Pleiotropic effects of statins: new aspects of the action of HMG-CoA reductase inhibitors. Medical news. 2004; 3: 59-66.
- Nesic Z. Acute protective effects of different doses of simvastatin in the rat model of renal ischemia-reperfusion injury. Acta Vet-Beograd. 2008; Vol. 58, 5-6: 413-427.
- Shtrygol S.Iu., Lisovyi V.M., Zupanets I.A. et al. Methods of experimental simulation of the kidney injury in the pharmacological studies: Methodological recommendations of the SPU of the HC of Ukraine. Kyiv; 2009. s.9-10.
- Law M.R., Wald N.J., Rudnicka A.R. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and metaanalysis.BMJ. 2003; Vol. 326: 1-7.
CrossRef
PubMed PubMedCentral
- Ozbek E., Cekmen M., Ilbey Y.O. et al. Atorvastatin prevents gentamicin-induced renal damage in rats through the inhibition of p38-MAPK and NF-kappaB pathways. Ren. Fail. 2009; 31(5): 382-392.
CrossRef
PubMed
- Issabeagloo E., Gharamaleki M.N., Kermanizadeh P., Abri B. Effect of lovastatin in prevention of renal lesions due to complete unilateral urethral obstruction in rats. Am. J. Sci. Res. 2012; 72: 89-98.
- Jabbari M., Rostami Z., Jenabi A. et al. Simvastatin ameliorates gentamicin-induced injury in rats. Saudi. J. Kid. Dis. Transp. 2011; Vol. 22, Iss. 6: 1181-1186.
PubMed
- European convention for the protection of the vertebrateanimals used for experimental and other scientific purpose: Council of Europe 18.03.1986. Strasbourg, 1986.
- Riabov S.I., Natochin Iu.V. Phunctional nephrology. Saint Petersburg: Lan', 1997.
- Mikheeva A.I., Bogodarova I.A. Methods of determining the total protein in the urine on the photoelectric colorimeter. Lab. delo. 1969; 7: 441-442.
- Berkhin E.B., Ivanov Iu.I. Methods of experimental study of the kidney and water-salt metabolism. Barnaul; 1972.
- Schettler G., Nussel E. Determination of triglycerides. Arbeitsmed.Sozialmed. Chol. Praventiv. Med. 1975; 10: 25.
- Goriachkovskii A.M. Clinical biochemistry. Odessa: Astroprint; 1998.
- Ueda I., Wada T. Determination of inorganic phosphate by the molybdovanadate method in the presence of ATP and some interfering organic bases. Anal. Biochem. 1970;Vol. 37, Iss. 1: 169-174.
CrossRef
|
|
|
|
|
|
|
© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.
|
|